American Society of Clinical Oncology endorses EAU Guideline on Muscle-Invasive and Metastatic Bladder Cancer
Last March 21st the American Society of Clinical Oncology (ASCO®) issued an endorsement of the European Association of Urology (EAU) Guidelines on Guideline on Muscle-Invasive and Metastatic Bladder Cancer (MIBC), 2015 edition. A 2016 update of the EAU MIBC Guidelines has just been released at the 31st Annual EAU Congress (Munich March 11-15, 2016).
ASCO® endorses all but one of the recommendations in the EAU MIBC Guidelines, by Witjes et al, with minor qualifying statements, including highlighting the use of chemoradiotherapy for select patients with MIBC and recommending inclusion of patients in clinical trials for the treatment of metastatic disease in the second-line setting. For this endorsement, only the recommendations relevant to treatment were assessed